Literature DB >> 21587275

Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants.

A A El-Sanhouri1, R E Foster, M R Petersen, R K Hutchins, D M Miller, T M Evans, N Trichopoulos, C D Riemann.   

Abstract

UNLABELLED: AIMS OR
PURPOSE: To determine the rate of retinal tears (RTs) after posterior vitreous detachment (PVD) and vitreous hemorrhage (VH) in patients on systemic anticoagulants.
METHODS: In all, 260 eyes of 260 patients with an acute PVD and VH were followed for evidence of an RT or detachment. Patients were divided into those taking systemic anticoagulants and those not taking anticoagulants.
RESULTS: A total of 137 patients (53%) were taking anticoagulants, 123 (47%) were not. Overall, 72% of patients not taking any anticoagulant had evidence of an RT, whereas 46% of patients taking an anticoagulant had an RT (P-value 0.0002). Also, 37% of patients not taking an anticoagulant had a retinal detachment (RD), whereas 23% of patients taking any anticoagulant had an RD (P-value 0.01).
CONCLUSIONS: In patients with an acute PVD and VH using anticoagulants, RTs and RDs were common. Anticoagulation status may be an important contributing factor in predicting the incidence of an RT or detachment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21587275      PMCID: PMC3178220          DOI: 10.1038/eye.2011.106

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  20 in total

1.  Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.

Authors:  Steve Charles; Philip J Rosenfeld; Steven Gayer
Journal:  Retina       Date:  2007-09       Impact factor: 4.256

2.  Flashes and floaters as predictors of vitreoretinal pathology: is follow-up necessary for posterior vitreous detachment?

Authors:  M R Dayan; D G Jayamanne; R M Andrews; P G Griffiths
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

3.  Thrombomodulin as a marker for bleeding complications during warfarin treatment.

Authors:  Marcus Lind; Kurt Boman; Lars Johansson; Torbjörn K Nilsson; Ann-Kristin Ohlin; Lisbeth Slunga Birgander; Jan-Håkan Jansson
Journal:  Arch Intern Med       Date:  2009-07-13

4.  Risk of retinal tears in patients with vitreous floaters.

Authors:  E E Boldrey
Journal:  Am J Ophthalmol       Date:  1983-12       Impact factor: 5.258

5.  Use of stroke secondary prevention services: are there disparities in care?

Authors:  Joseph S Ross; Ethan A Halm; Dawn M Bravata
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

6.  Correlation between vitreous pigment granules and retinal breaks in eyes with acute posterior vitreous detachment.

Authors:  R D Brod; D A Lightman; A J Packer; H P Saras
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

7.  Type 2 diabetes: Which interventions best reduce absolute risks of adverse events?

Authors:  Brian Firestone; James W Mold
Journal:  J Fam Pract       Date:  2009-06       Impact factor: 0.493

8.  Return-to-duty rates among coalition forces treated in a forward-deployed pain treatment center: a prospective observational study.

Authors:  Ron L White; Steven P Cohen
Journal:  Anesthesiology       Date:  2007-12       Impact factor: 7.892

9.  Incidence of posterior vitreous detachment after cataract surgery.

Authors:  Alireza Mirshahi; Fabian Höhn; Katrin Lorenz; Lars-Olof Hattenbach
Journal:  J Cataract Refract Surg       Date:  2009-06       Impact factor: 3.351

10.  The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.

Authors:  J D Benzimra; R L Johnston; P Jaycock; P H Galloway; G Lambert; A K K Chung; T Eke; J M Sparrow
Journal:  Eye (Lond)       Date:  2008-02-08       Impact factor: 3.775

View more
  1 in total

1.  Effect of Hemodialysis on Eye Coats, Axial Length, and Ocular Perfusion Pressure in Patients with Chronic Renal Failure.

Authors:  Ling Wang; Gang Yin; Zhiying Yu; Nan Chen; Dabo Wang
Journal:  J Ophthalmol       Date:  2018-02-08       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.